Castle Biosciences Inc (CSTL)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,093,978,000
EV to revenue ratio (TTM)
2.34
EV to ebitda
42.95
Financial Performance
Revenue (TTM)
357,278,000
Gross profit (TTM)
276,026,000
EBITDA
-16,516,000
Profitability
Operating margin (TTM)
-2.96%
Profit margin
-5.43%
Return on assets (TTM)
-1.36%
Return on equity (TTM)
-4.20%
Per Share Metrics
Revenue per share (TTM)
12.04
EPS
-0.64
Diluted EPS (TTM)
-0.64
Book value
15.41
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
3.062
Price to book ratio (TTM)
2.268
Growth
Quarterly earnings growth (YoY)
20.10%
Quarterly revenue growth (YoY)
-51.60%
Analyst Sentiment
Strong buy
0
Buy
9
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.996